Frozen Food Development packed ready-to-eat frozen produce under rodent activity and lacked required pathogen controls.
What happened
FDA inspected the company's IQF packing and re-packing facility in Elizabethtown, PA, on October 10–13, 2023, and November 30, 2023. Investigators found rodent excreta pellets too numerous to count in warehouses, storage areas, and freezers, including near exposed ready-to-eat produce and food-contact packaging. FDA also found the company lacked a required supply-chain program for pathogens in frozen RTE produce and had not evaluated Cyclospora in frozen RTE berries.
What FDA found
FDA found rodent excreta pellets too numerous to count in storage and freezer areas, including where exposed ready-to-eat produce and food-contact packaging were held.
21 CFR 117.35(c)The company did not establish and implement a risk-based supply-chain program for ingredients with a hazard needing a supply-chain-applied control, and its plan did not provide the required annual onsite supplier audits or a written determination that other verification was adequate.
21 CFR 117.405(a)(1); 21 CFR 117.430(b)The company did not identify and evaluate Cyclospora as a known or reasonably foreseeable hazard in frozen ready-to-eat berries to determine whether it required a preventive control.
21 CFR 117.130(a)(1)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of this letter of the specific steps taken to address the violations, including an explanation and documentation to prevent recurrence. If corrective actions cannot be completed in that time, the company must state the reason and the timeframe.
Who should pay attention
- brands that buy finished frozen RTE produce from this packer
- retailers and foodservice operators selling frozen berries, mixed fruit, or other RTE produce
- suppliers and co-packers that rely on supplier audits for pathogen control
This is a summary. Read the original letter on fda.gov.